Package 25021-262-10

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "17982e48-31b2-4b74-896f-b7f61b1e54ad", "openfda": {"nui": ["N0000175604", "N0000175075"], "unii": ["69G8BD63PP"], "rxcui": ["402243"], "spl_set_id": ["945fbaf0-7a79-4676-aa90-e9a213c0654f"], "pharm_class_epc": ["Proteasome Inhibitor [EPC]"], "pharm_class_moa": ["Proteasome Inhibitors [MoA]"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-262-10)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "25021-262-10", "marketing_start_date": "20250515"}], "brand_name": "BORTEZOMIB", "product_id": "25021-262_17982e48-31b2-4b74-896f-b7f61b1e54ad", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Proteasome Inhibitor [EPC]", "Proteasome Inhibitors [MoA]"], "product_ndc": "25021-262", "generic_name": "BORTEZOMIB", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BORTEZOMIB", "active_ingredients": [{"name": "BORTEZOMIB", "strength": "3.5 mg/1"}], "application_number": "ANDA210824", "marketing_category": "ANDA", "marketing_start_date": "20250515", "listing_expiration_date": "20261231"}